ライフサイエンスコーパス: Enterobacter

1 t may be subject to limitations when testing Enterobacter.

2 cteria including Pseudomonas, Shewanella and Enterobacter.

3 lus influenzae (19%), Pseudomonas (11%), and Enterobacter (11%).

4 this test using PB against larger numbers of Enterobacter A total of 143 nonduplicate Enterobacter is

5 acter cloacae (21), Acinetobacter spp. (13), Enterobacter aerogenes (11), Citrobacter spp. (10), Pseu

6 ter spp. (6.2%), Serratia marcescens (5.5%), Enterobacter aerogenes (4.4%), Stenotrophomonas maltophi

7 actam (<1% difference) for 6,938 isolates of Enterobacter aerogenes and 13,954 isolates of Enterobact

8 selectivity of the method was examined with Enterobacter aerogenes and Enterobacter dissolvens, whic

9 seudomonas species, Serratia marcescens, and Enterobacter aerogenes in most of the trials.

10 Glycerophosphodiesterase (GpdQ) from Enterobacter aerogenes is a nonspecific diesterase that

11 mmon CRE species were Klebsiella pneumoniae, Enterobacter aerogenes, and Escherichia coli.

12 the human pathogens Klebsiella pneumonia and Enterobacter aerogenes, and would seem to suggest a subc

13 Escherichia coli, Citrobacter freundii, and Enterobacter aerogenes, as well as Gram-positive Bacillu

14 c media prepared with live or dead bacteria (Enterobacter aerogenes, E. coli, Klebsiella pneumoniae,

15 um cephalosporin-resistant Escherichia coli, Enterobacter aerogenes, Enterobacter cloacae complex, Kl

16 ium, Serratia marcescens, Shigella flexneri, Enterobacter aerogenes, Klebsiella pneumoniae, Yersinia

17 oniae ACT-1, and the AmpC beta-lactamases of Enterobacter aerogenes, Morganella morganii, and Citroba

18 several bacteria, such as Escherichia coli, Enterobacter aerogenes, Pseudomonas aeruginosa and Salmo

19 90 Enterobacter cloacae, and one (1%) of 162 Enterobacter aerogenes.

20 rains of E. coli, Klebsiella pneumoniae, and Enterobacter aerogenes.

21 an IncPbeta plasmid previously isolated from Enterobacter aerogenes.

22 oculated onto nonnutrient agar overlaid with Enterobacter aerogenes.

23 Proteus mirabilis, Citrobacter freundii and Enterobacter agglomerans [cyclo(DeltaAla-L-Val) only].

24 Citrobacter freundii, Klebsiella pneumoniae, Enterobacter agglomerans, and Shigella spp.

25 nism include its biochemical similarities to Enterobacter agglomerans, its apparent ability to cause

26 es are related to the chromosomal enzymes of Enterobacter and Citrobacter spp. and also mediate resis

27 Enterobacter and Serratia proliferation was impeded in t

28 In contrast, Enterobacter and/or Pseudomonas were isolated primarily

29 trogenesis by members of the genera Vibrio , Enterobacter , and Citrobacter and by Bacillus stratosph

30 25% of individual species of Acinetobacter, Enterobacter, and coagulase-negative staphylococci recov

31 ntly caused by Enterococcus, Staphylococcus, Enterobacter, and Klebsiella.

32 eat that CO cannot differentiate Klebsiella, Enterobacter, and Serratia spp., enteric pathogens were

33 rial genera, including Salmonella, Yersinia, Enterobacter, and species of the plant pathogen, Erwinia

34 Members of the genus Enterobacter are commensal organisms of the gastrointest

35 he genera Stenotrophomonas, Pseudomonas, and Enterobacter are responsible for defense suppression.

36 Enterobacter bacteremia, invasive aspergillosis, and dis

37 We have identified an Enterobacter bacterium isolated from wild mosquito popul

38 ia, Bacillus, Pseudomonas, Serratia, Hafnia, Enterobacter, Citrobacter, and Lactobacillus.

39 m patients were Pseudomonas aeruginosa (22), Enterobacter cloacae (21), Acinetobacter spp. (13), Ente

40 coli (18.8%), Klebsiella pneumoniae (14.2%), Enterobacter cloacae (9.1%), Acinetobacter spp. (6.2%),

41 hogens with interpretive criteria, excluding Enterobacter cloacae (98.3% S) and E. faecalis (86.0% S)

42 m Staphylococcus aureus, and aac(3)-VIa from Enterobacter cloacae (conferring resistance to kanamycin

43 (n = 1,127), Escherichia coli (n = 149), and Enterobacter cloacae (n = 110).

44 ther Staphylococcus epidermidis (n = 100) or Enterobacter cloacae (n = 60).

45 1.9%), Escherichia coli (n = 129, 30.0%) and Enterobacter cloacae (n = 62, 14.4%) were the main Enter

46 The oxygen-insensitive nitroreductase from Enterobacter cloacae (NR) catalyzes two-electron reducti

47 linically important enzymes CTX-M-15, KPC-2, Enterobacter cloacae AmpC, Pseudomonas aeruginosa AmpC,

48 usly determined for the class C enzymes from Enterobacter cloacae and Citrobacter freundii.

49 rial cell wall biosynthetic enzyme MurA from Enterobacter cloacae and Escherichia coli in vitro.

50 A case of ventriculitis due to Enterobacter cloacae and Pseudomonas fulva following pla

51 microbial bacteremia, and seven of these had Enterobacter cloacae and S. marcescens in the same cultu

52 stant (IC(50), approximately 10,000 nM), and Enterobacter cloacae and Serratia marcescens were highly

53 L49 antibodies were chemically conjugated to Enterobacter cloacae beta-lactamase (bL), and their abil

54 nd the increasing clinical importance of the Enterobacter cloacae complex have often been discussed.

55 nt Escherichia coli, Enterobacter aerogenes, Enterobacter cloacae complex, Klebsiella pneumoniae, or

56 The Enterobacter cloacae GC1 enzyme is an example of a class

57 The crystallographic structure of the Enterobacter cloacae GC1 extended-spectrum class C beta-

58 structure of the nitroreductase enzyme from Enterobacter cloacae has been determined for the oxidize

59 Enterobacter cloacae has been implicated as one of the c

60 Recently, enteric commensal bacteria Enterobacter cloacae has been recognized as a helper in

61 rganisms, intraocular infection secondary to Enterobacter cloacae infection is a devastating disease

62 Enterobacter cloacae is a clinically important Gram-nega

63 We describe an Enterobacter cloacae isolate harbouring a minor subpopul

64 iae isolates, 3 Escherichia coli isolates, 5 Enterobacter cloacae isolates, 2 S. marcescens isolates,

65 the x-ray structures of the D305A mutant of Enterobacter cloacae MurA and the D313A mutant of Escher

66 tured and depicted the Cys-115-PEP adduct of Enterobacter cloacae MurA in various reaction states by

67 ablished that Cys115 of Escherichia coli and Enterobacter cloacae MurA is the active site nucleophile

68 s been determined to be 8.3, by titration of Enterobacter cloacae MurA with the alkylating agent iodo

69 d the x-ray structure of the C115S mutant of Enterobacter cloacae MurA, which was crystallized in the

70 ies of the flavin mononucleotide cofactor of Enterobacter cloacae nitroreductase (NR), determined und

71 A library of Enterobacter cloacae P99 beta-lactamase mutants was prod

72 ed reaction, cephalosporin hydrolysis by the Enterobacter cloacae P99 cephalosporinase (beta-lactam h

73 dase of Streptomyces sp. R61, a PBP, and the Enterobacter cloacae P99 cephalosporinase, a class C bet

74 inhibition of the class C beta-lactamase of Enterobacter cloacae P99 determined.

75 e) inactivates the class C beta-lactamase of Enterobacter cloacae P99 in a covalent fashion.

76 to react with the class C beta-lactamase of Enterobacter cloacae P99 in two ways, by acylation and b

77 stants for hydrolysis by beta-lactamase from Enterobacter cloacae P99 indicated kcat values of 476 +/

78 The class C beta-lactamase of Enterobacter cloacae P99 is closely similar in structure

79 The class C beta-lactamase of Enterobacter cloacae P99 is competitively inhibited by l

80 The class C serine beta-lactamase of Enterobacter cloacae P99 is irreversibly inhibited by O-

81 cts on V/K for the class C beta-lactamase of Enterobacter cloacae P99 suggest an acyl-transfer transi

82 The class C beta-lactamase of Enterobacter cloacae P99 was employed.

83 hibited typical class A (TEM-2) and class C (Enterobacter cloacae P99) beta-lactamases in a time-depe

84 , catalyzed by the class C beta-lactamase of Enterobacter cloacae P99, have been studied in order to

85 -2 antibody detected Escherichia coli CMY-2, Enterobacter cloacae P99, Klebsiella pneumoniae ACT-1, a

86 nactivators of the class C beta-lactamase of Enterobacter cloacae P99.

87 by class C beta-lactamases such as that from Enterobacter cloacae P99.

88 omyces R61 and the class C beta-lactamase of Enterobacter cloacae P99.

89 rally very similar class C beta-lactamase of Enterobacter cloacae P99.

90 The membrane-bound selenate reductase of Enterobacter cloacae SLD1a-1 is purified in low yield an

91 Enterobacter cloacae strain G6809 with reduced susceptib

92 C beta-lactamase from a clinical isolate of Enterobacter cloacae strain GC1 with improved hydrolytic

93 fication of a Shiga toxin 1 (Stx1)-producing Enterobacter cloacae strain, M12X01451, from a human cli

94 nterobacter aerogenes and 13,954 isolates of Enterobacter cloacae tested using a Vitek system; for th

95 ing the melibiose-H(+) symporter (MelY) from Enterobacter cloacae that had enhanced fermentation on 1

96 rates higher than the totals were noted with Enterobacter cloacae versus ampicillin-sulbactam, aztreo

97 e given 1 x 10(6) colony-forming units/mL of Enterobacter cloacae with the third feeding.

98 LY]) and Enterobacter lignolyticus (formerly Enterobacter cloacae) SCF1 (enterolysin [ELY]).

99 er inoculation of their endophytic bacteria (Enterobacter cloacae).

100 inst Escherichia coli, Klebsiella pneumonia, Enterobacter cloacae, Acinetobacter baumannii, and methi

101 348 Klebsiella pneumoniae, one (<1%) of 890 Enterobacter cloacae, and one (1%) of 162 Enterobacter a

102 d -negative strains), Klebsiella pneumoniae, Enterobacter cloacae, and Pseudomonas aeruginosa.

103 a: Escherichia coli, Pseudomonas aeruginosa, Enterobacter cloacae, and Yersinia enterocolitica.

104 oci from isolates of Serratia marcescens and Enterobacter cloacae, demonstrating the presence of in-f

105 y Citrobacter freundii, Clostridium species, Enterobacter cloacae, Enterococcus faecalis, Klebsiella

106 fied in the Enterobacteria Escherichia coli, Enterobacter cloacae, Erwinia herbicola, and Salmonella

107 ing probes for pathogenic bacteria including Enterobacter cloacae, Escherichia coli J96, Pseudomonas

108 isolates of important Gram-negative species-Enterobacter cloacae, Escherichia coli, Klebsiella pneum

109 several gram-negative bacteria, specifically Enterobacter cloacae, Pseudomonas aeruginosa, and Pantoe

110 , invasive aspergillosis (20%, 3 of 15), and Enterobacter cloacae, Serratia marcescens, Pneumocystis

111 mis, E. coli O157:H7, Klebsiella pneumoniae, Enterobacter cloacae, Shigella dysenteriae, Salmonella e

112 neage - accumulates LDs when challenged with Enterobacter cloacae, Sindbis, and Dengue viruses.

113 erial species such as Klebsiella pneumoniae, Enterobacter cloacae, Stenotrophomonas maltophilia, and

114 antibiotic for treatment of infections with Enterobacter cloacae.

115 robacter koseri but 97.0% similar to that of Enterobacter cloacae.

116 d by blood feeding, restored the immunity to Enterobacter cloacae.

117 illus, which most laboratories recognized as Enterobacter cloacae.

118 escens after injection of prepupae with live Enterobacter cloacae.

119 hich is identical to plasmid pNDM-HF727 from Enterobacter cloacae.

120 gle D(H) gene segment (D-limited mice), with Enterobacter cloacae.

121 onse to alpha-1,3 dextran (DEX) expressed on Enterobacter cloacae.

122 ence analysis revealed that the organism was Enterobacter cloacae.

123 t on four cases of endophthalmitis caused by Enterobacter cloacae: two in patients with acute postope

124 was examined with Enterobacter aerogenes and Enterobacter dissolvens, which did not produce any signi

125 a decrease in Clostridium and an increase in Enterobacter, Escherichia/Shigella, and Pseudomonas in s

126 the Escherichia, Salmonella, Klebsiella, and Enterobacter genera possess only a single LuxR homolog,

127 rs of the genera Escherichia, Klebsiella and Enterobacter, genera commonly associated with nosocomial

128 lla pneumoniae carbapenemase (KPC)-producing Enterobacter gergoviae.

129 osa, Enterocococcus spp., and the Klebsiella-Enterobacter group.

130 l samples included Enterococcus faecalis and Enterobacter hormaechei.

131 Carbapenems are recommended for treatment of Enterobacter infections with AmpC phenotypes.

132 describe the isolation and identification of Enterobacter intermedium from the gallbladder of a patie

133 of Enterobacter A total of 143 nonduplicate Enterobacter isolates (102 E. cloacae complex, 41 E. aer

134 One hundred four Enterobacter isolates were tested by standard CLSI disk

135 Of 143 Enterobacter isolates, 25 were determined to be PB resis

136 del 1981 (DSM 2032) (desulfolysin [DLY]) and Enterobacter lignolyticus (formerly Enterobacter cloacae

137 We previously isolated Enterobacter lignolyticus strain SCF1, a lignocellulolyt

138 hanism consisting of two adjacent genes from Enterobacter lignolyticus, a rain forest soil bacterium

139 cteria identified in field-collected H. zea, Enterobacter ludwigii, induced expression of the tomato

140 immunized with this alpha-1,3-glucan-bearing Enterobacter (MK7) are protected against cockroach aller

141 , Serratia marcescens, Vibrio vulnificus and Enterobacter nimipressuralis.

142 iation was identified in rates of BSI due to Enterobacter or Serratia species.

143 Three of these were Enterobacter (Pantoea) species and four of these were Sh

144 ential surface colonizers such as Aeromonas, Enterobacter, Pseudomonas, and Thauera.

145 Enterobacter sakazakii (ES) is an emerging pathogen that

146 In 1994, an outbreak of Enterobacter sakazakii infections occurred in a neonatal

147 Enterobacter sakazakii is an emerging pathogen that has

148 The phylogenetic relationships of Enterobacter sakazakii strains were investigated using 1

149 Enterococcus aerogenes, Proteus vulgaris and Enterobacter sakazakii) bacteria, with decoction present

150 Cronobacter (previously known as Enterobacter sakazakii) is a diverse bacterial genus con

151 Enterobacter sakazakii, a common contaminant of milk-bas

152 vehicle for an emerging foodborne pathogen, Enterobacter sakazakii, resulting in high mortality rate

153 E. coli and the Enterobacter sp. achieved high populations in hemolymph,

154 er per os challenge with exogenous bacteria (Enterobacter sp. and Serratia marcescens strain Db11) an

155 exodon) was hydrolysed and used to cultivate Enterobacter sp. C2361 and Providencia sp. C1112 for the

156 On the other hand, the Enterobacter sp. C2361 produced lower MTGase activity (1

157 characterized a natural bacterial endophyte, Enterobacter sp. strain PDN3, of poplar trees, that rapi

158 cticidal activity, and reestablishment of an Enterobacter sp. that normally resides in the midgut mic

159 An isolate of Enterobacter sp. was obtained from the microbial communi

160 taphylococci, 1 Enterococcus faecalis, and 1 Enterobacter sp.) on terminal subculture of the AER bott

161 d a root-inhabiting bacterial endophyte, M6 (Enterobacter sp.).

162 d extended-spectrum beta-lactamase-producing Enterobacter species [5]).

163 an Ab to microbial alpha-1,3-glucan binds an Enterobacter species and cockroach allergen.

164 Carbapenem-resistant Enterobacter species are emerging nosocomial pathogens.

165 ree hundred sixty-eight patients experienced Enterobacter species bacteremia and received at least 1

166 We reviewed all cases of Enterobacter species bacteremia at 2 academic hospitals

167 efficacy as carbapenems for the treatment of Enterobacter species bacteremia.

168 tation of polymyxin susceptibility tests for Enterobacter species should be undertaken with extreme c

169 t with P. aeruginosa, Klebsiella species, or Enterobacter species susceptible to one of the marker an

170 piperacillin-tazobactam in P. aeruginosa and Enterobacter species).

171 in Escherichia coli, Klebsiella pneumoniae, Enterobacter species, and Pseudomonas aeruginosa.

172 For polymyxin susceptibility testing of Enterobacter species, close attention must be paid to th

173 ae (Klebsiella pneumoniae, Escherichia coli, Enterobacter species, etc.), Pseudomonas aeruginosa, and

174 Erwinia rhapontici, Pantoea agglomerans, and Enterobacter species.

175 osa, 174 for Klebsiella species, and 106 for Enterobacter species.

176 oorly, especially among Escherichia coli and Enterobacter species.

177 e, or intra-abdominal fluid cultures growing Enterobacter spp, Serratia spp, or Citrobacter spp were

178 ically relevant class C beta-lactamases from Enterobacter spp. and Pseudomonas aeruginosa.

179 ants carrying abnormal flora Pseudomonas and Enterobacter spp. predominated.

180 scens, 5/6 with Citrobacter spp., 13/14 with Enterobacter spp., 23/24 with E. coli, 2/3 with K. oxyto

181 neumoniae, 92.9%; Klebsiella oxytoca, 95.5%; Enterobacter spp., 99.3%; Pseudomonas aeruginosa, 98.9%;

182 robacter koseri, Citrobacter freundii group, Enterobacter spp., and Serratia marcescens.

183 rgets (Acinetobacter spp., Citrobacter spp., Enterobacter spp., Escherichia coli/Shigella spp., Klebs

184 dred consecutive, single patient isolates of Enterobacter spp., Serratia spp., Citrobacter spp., and

185 antly Escherichia coli, Klebsiella spp., and Enterobacter spp., with counts up to 10(8) CFU/g.

186 s), the second by Proteobacteria (Klebsiella/Enterobacter), the third by Bacteriodetes, and the fourt